| RYSUNVY GlaxoSmithKline Biologicals SA
97052319 29 Sep 2021 | on 17 Jan 2022 | (Based on Intent to Use) Vaccines; Pharmaceutical preparations and sub... Class 005 Class 005 Pharmaceutical Products (Based on Intent to Use) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | RYDELVY Bristol-Myers Squibb Company
85850357 14 Feb 2013 | on 09 Dec 2013 | Pharmaceutical preparations for human use,Pharmaceutical preparations ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use | | 
